A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction.

Le DT; Brockstedt DG; Nir-Paz R; Hampl J; Mathur S; Nemunaitis J; Sterman DH; Sterman DH; Hassan R; Lutz E

doi:10.1158/1078-0432.ccr-11-2121

A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction.

Identifier:nobleid.org/w1/20260526/2C90F680

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2C90F680.svg?ark=w1%2F20260526%2F2C90F680)](https://nobleid.org/work/w1/20260526/2C90F680)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction.

Identifier:nobleid.org/w1/20260526/2C90F680

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2C90F680.svg?ark=w1%2F20260526%2F2C90F680)](https://nobleid.org/work/w1/20260526/2C90F680)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work